North America Hormone Replacement Therapy Market Share, Size, Forecast and Trends by 2021
North America Hormone Replacement Therapy Market is estimated at USD 6.77 billion in 2016 and is predicted to reach USD 9.55 billion by 2021, growing at a CAGR of 7.12%.
(EMAILWIRE.COM, July 06, 2017 ) Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed. The North America Hormone Replacement Therapy Market is estimated at USD 6.77 billion in 2016 and is predicted to reach USD 9.55 billion by 2021, growing at a CAGR of 7.12%.
Full report at: http://www.marketdataforecast.com/market-reports/north-america-hormone-replacement-therapy-market-959/
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of North America hormone replacement therapy market.
However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, high cost of therapy is limiting its reach to middle class people. Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of target audience.
The North America hormone replacement therapy is segmented on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. The estrogen replacement therapy is the major segment as its employed by majority women to treat menopause, and is followed by growth hormone replacement therapy. Further, on the basis of route of administration the market is classified as oral, transdermal, parenteral, and other routes. Most of the times, therapies are carried out through oral routes, followed by parenteral administrations.
Morover, on the basis of geography, the North America hormone replacement therapy market is analysed under USA and Canada countries. USA dominates the market in the region owing to the economic conditions, awareness among women and government reimbursement policies present.
Request sample:http://www.marketdataforecast.com/market-reports/north-america-hormone-replacement-therapy-market-959/request-sample
Some of the key players operating in the North America hormone replacement industry are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer,Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Full report at: http://www.marketdataforecast.com/market-reports/north-america-hormone-replacement-therapy-market-959/
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of North America hormone replacement therapy market.
However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, high cost of therapy is limiting its reach to middle class people. Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of target audience.
The North America hormone replacement therapy is segmented on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. The estrogen replacement therapy is the major segment as its employed by majority women to treat menopause, and is followed by growth hormone replacement therapy. Further, on the basis of route of administration the market is classified as oral, transdermal, parenteral, and other routes. Most of the times, therapies are carried out through oral routes, followed by parenteral administrations.
Morover, on the basis of geography, the North America hormone replacement therapy market is analysed under USA and Canada countries. USA dominates the market in the region owing to the economic conditions, awareness among women and government reimbursement policies present.
Request sample:http://www.marketdataforecast.com/market-reports/north-america-hormone-replacement-therapy-market-959/request-sample
Some of the key players operating in the North America hormone replacement industry are Novartis, Abbott Laboratories, Pfizer, Mylan Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer,Novo Nordisk, Wyeth, Hisamitsu Pharmaceutical Co. Inc.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results